Phase I Study of Chimeric Human/Murine Anti–Ganglioside G_D2Monoclonal Antibody (ch14.18) With Granulocyte-Macrophage Colony-Stimulating Factor in Children With Neuroblastoma Immediately After Hematopoietic Stem-Cell Transplantation: A Children’s Cancer Group Study

Mouse/human chimeric monoclonal antibody in man: kinetics and immune response.

1989 • 526 citations

Detection of ganglioside GD2 in tumor tissues and sera of neuroblastoma patients.

1984 • 364 citations

Monoclonal antibodies to a glycolipid antigen on human neuroblastoma cells.

1985 • 317 citations

Phase I trial of a human-mouse chimeric anti-disialoganglioside monoclonal antibody ch14.18 in patients with refractory neuroblastoma and osteosarcoma.

1998 • 245 citations

A phase I study of human/mouse chimeric antiganglioside GD2 antibody ch14.18 in patients with neuroblastoma

1995 • 211 citations

Gangliosides and allied glycosphingolipids in human peripheral nerve and spinal cord

1994 • 185 citations

Natural Killer Cell–Mediated Eradication of Neuroblastoma Metastases to Bone Marrow by Targeted Interleukin-2 Therapy

1998 • 183 citations

Targeted Interleukin-2 Therapy for Spontaneous Neuroblastoma Metastases to Bone Marrow

1997 • 176 citations

Consolidation chemoradiotherapy and autologous bone marrow transplantation versus continued chemotherapy for metastatic neuroblastoma: a report of two concurrent Children's Cancer Group studies.

1996 • 167 citations

GM-CSF enhances 3F8 monoclonal antibody-dependent cellular cytotoxicity against human melanoma and neuroblastoma

1989 • 166 citations

Effect of a chimeric anti-ganglioside GD2 antibody on cell-mediated lysis of human neuroblastoma cells.

1991 • 160 citations

High-level expression of chimeric antibodies using adapted cDNA variable region cassettes

1989 • 158 citations

Augmentation of antibody dependent cell mediated cytotoxicity following in vivo therapy with recombinant interleukin 2.

1990 • 156 citations

A Phase I/IB trial of murine monoclonal anti-GD2 antibody 14.G2a plus interleukin-2 in children with refractory neuroblastoma

1997 • 154 citations

Functional properties and effect on growth suppression of human neuroblastoma tumors by isotype switch variants of monoclonal antiganglioside GD2 antibody 14.18.

1989 • 144 citations

Improved survival at 2 and 5 years in the LMCE1 unselected group of 72 children with stage IV neuroblastoma older than 1 year of age at diagnosis: is cure possible in a small subgroup?

1991 • 142 citations

High-dose chemoradiotherapy supported by marrow infusions for advanced neuroblastoma: a Pediatric Oncology Group study.

1991 • 124 citations

Phase I trial of the chimeric anti-GD2 monoclonal antibody ch14.18 in patients with malignant melanoma

1992 • 119 citations

Complete Tumor Ablation With Iodine 131-Radiolabeled Disialoganglioside GD2-Specific Monoclonal Antibody Against Human Neuroblastoma Xenografted in Nude Mice23

1986 • 117 citations

Antibody-dependent cellular cytotoxicity mediated by murine lymphocytes activated in recombinant interleukin 2.

1987 • 97 citations

A mechanism for neutrophil-mediated lysis of human neuroblastoma cells.

1993 • 74 citations

Treatment of Neuroblastoma Patients with Antiganglioside GD2 Antibody plus Interleukin-2 Induces Antibody-Dependent Cellular Cytotoxicity Against Neuroblastoma Detected In Vitro

1994 • 73 citations

Phase IB trial of chimeric antidisialoganglioside antibody plus interleukin 2 for melanoma patients.

1997 • 71 citations

Pharmacokinetics of human-mouse chimeric anti-GD2 mAb ch14.18 in a phase I trial in neuroblastoma patients

1995 • 61 citations

Phase Ia/Ib Trial of Anti-GD2 Chimeric Monoclonal Antibody 14.18 (ch l4.18) and Recombinant Human Granulocyte-Macrophage Colony-Stimulating Factor (rhGM-CSF) in Metastatic Melanoma

1996 • 37 citations

Specific enhancement of the therapeutic effect of anti-idiotype antibodies on a murine B cell lymphoma by IL-2.

1988 • 34 citations

Minor human antibody response to a mouse and chimeric monoclonal antibody after a single i.v. infusion in ovarian carcinoma patients: a comparison of five assays

1995 • 29 citations

Specific Enzyme-Linked Immunosorbent Assays for Quantitation of Antibody-Cytokine Fusion Proteins

1999 • 19 citations